Cleared Traditional

K202443 - Smart Kit Basic, Smart Kit Pro
(FDA 510(k) Clearance)

Mar 2021
Decision
197d
Days
Class 2
Risk

K202443 is an FDA 510(k) clearance for the Smart Kit Basic, Smart Kit Pro. This device is classified as a System, Suction, Lipoplasty (Class II - Special Controls, product code MUU).

Submitted by Bsl Co., Ltd. (Gimhae-Si, KR). The FDA issued a Cleared decision on March 11, 2021, 197 days after receiving the submission on August 26, 2020.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.5040. See Federal Register Notice At 86 Fr 50887 ?consolidation Of Devices That Process Autologous Human Cells, Tissues, And Cellular And Tissue-based Products At The Point Of Care To Produce A Therapeutic Article? (frn) (fda-2021-n-0881)..

Submission Details

510(k) Number K202443 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 2020
Decision Date March 11, 2021
Days to Decision 197 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code MUU — System, Suction, Lipoplasty
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.5040
Definition See Federal Register Notice At 86 Fr 50887 ?consolidation Of Devices That Process Autologous Human Cells, Tissues, And Cellular And Tissue-based Products At The Point Of Care To Produce A Therapeutic Article? (frn) (fda-2021-n-0881).

Similar Devices — MUU System, Suction, Lipoplasty

All 39
IntelliFat Disposable Adipose Tissue Harvesting and Transfer Kit, IntelliFat Body On Demand (BOD) Kit
K210528 · Millennium Medical Technologies Inc (Dba Cellmyx) · Mar 2022
SyntrFuge System
K203800 · Syntr Health Technologies, Inc. · Jul 2021
REVOLVE ENVI 600 Advanced Adipose System
K193539 · Lifecell Corporation · May 2020
Dermapose Refresh
K193363 · Puregraft, LLC · Apr 2020
JTL-250-01
K182732 · Jointechlabs, Inc. · Nov 2019
Progenikine Concentrating System 25 mL System
K191564 · Emcyte Corporation · Nov 2019